Evidence map›Paper›PMID 32424603›Full record

ReviewIrish journal of medical science2020

COVID-19 in adults: test menu for hospital blood science laboratories.

Paula M O'Shea, Graham Robert Lee, Tomás P Griffin, Vincent Tormey, Amjad Hayat, Seán J Costelloe, Damian Gerard Griffin, Saradha Srinivasan, Maurice O'Kane, Conor M Burke and 4 more

Abstract readReview
In one paragraph

Review in Irish journal of medical science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Observational
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Paula M O'SheaDepartment of Clinical Biochemistry, Saolta University Health Care Group (SUHCG), Galway University Hospitals, Newcastle Road, Galway, Ireland. PaulaM.OShea@hse.ie.ORCID http://orcid.org/0000-0001-9392-1711
Graham Robert LeeDepartment of Clinical Biochemistry and Diagnostic Endocrinology, Mater Misericordiae University Hospital, Dublin, Ireland.
Tomás P GriffinCentre for Diabetes and Metabolism, SUHCG, Galway University Hospitals, Galway, Ireland.
Vincent TormeyDepartment of Immunology, SUHCG, Galway University Hospitals, Galway, Ireland.
Amjad HayatDepartment of Haematology, University Hospital Galway, Galway, Ireland.
Seán J CostelloeDepartment of Clinical Biochemistry, Cork University Hospital, Cork, Ireland.
Damian Gerard GriffinDepartment of Clinical Biochemistry, Saolta University Health Care Group (SUHCG), Galway University Hospitals, Newcastle Road, Galway, Ireland.
Saradha SrinivasanDepartment of Chemical Pathology, Beaumont Hospital, Dublin 9, Ireland.
Maurice O'KaneDepartment of Clinical Chemistry, Altnagelvin Hospital, Derry, Northern Ireland.
Conor M BurkeDepartment of Respiratory Medicine, Connolly Hospital Blanchardstown, Dublin 15, Ireland.
John FaulDepartment of Respiratory Medicine, Connolly Hospital Blanchardstown, Dublin 15, Ireland.
Christopher J ThompsonDepartment of Endocrinology, Beaumont Hospital, Dublin 9, Ireland.
Gerard CurleyDepartment of Anaesthesia and Critical Care, Royal College of Surgeons, Dublin, Ireland.
William P TormeyDepartment of Chemical Pathology, Beaumont Hospital, Dublin 9, Ireland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCoronavirus disease 2019 (COVID-19), is a respiratory illness caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The Clinical Blood Sciences Laboratory (CBSL) plays a key role in supporting the monitoring and management of patients with COVID-19 disease.

objectiveTo provide a comprehensive CBSL testing protocol to support the medical management of SARS-CoV-2 infection.

methodsDescription of the biochemical, haematological and immunological tests that have a role in the assessment and monitoring of patients with COVID-19 infection.

resultsWe provide a test menu for clinical laboratories to ensure the effective monitoring, management and prognostication of COVID-19 patients in hospital.

conclusionGiven the rapidity with which patients with COVID-19 disease can deteriorate, we recommend regular testing with vigilance paid to the rate and trajectory of change in each of these parameters.

Indexed as

BetacoronavirusClinical Laboratory TechniquesAdultCoronavirus InfectionsCOVID-19COVID-19 TestingFemaleHumansPandemicsPneumonia, ViralSARS-CoV-2Blood science testingCOVID-19Hospital laboratoriesMonitoring and management

Identifiers

PMID32424603
PMCPMC7232920

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.